CTC Alternative Strategies, Ltd.

Position in LLY — ELI LILLY & Co

CIK 1569550 CHICAGO, IL

Position in LLY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$671,680

-$331,920 QoQ

Shares Held

560

-56.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.43%

of 13F equity value

Holder Rank

#3,493

of 4,605 holders

Holding Since

Sep 2024

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CTC Alternative Strategies, Ltd. holds $4,726,536 across 6 Drug Manufacturers - General names. LLY ranks #2 (14.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	11,400	$2,868,696
2	LLY	ELI LILLY & Co This page	560	$671,680
3	GILD	Gilead Sciences, Inc.	3,000	$379,020
4	JNJ	Johnson & Johnson	1,400	$355,558
5	MRK	Merck & Co., Inc.	1,900	$244,150
6	BMY	Bristol Myers Squibb Co	3,600	$207,432

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$671,680	560	-56.9%	Shares	Sole	2026-08-13
2024-12-31	$1,003,600	1,300	+107.7%	Shares	Sole	2025-02-19
2024-09-30	$554,598	626	—	Shares	Sole	2024-11-15
No filing history on record for this holder in this stock.